HPV vaccine effectiveness against cervical cancer (VIDEO)

A newly-published study identified specific groups of higher-risk children that could benefit most from monoclonal antibodies.

The news is full of stories about monkeypox, the recent changes to COVID-19 guidance, and the return of polio cases. What do clinicians need to know?

The American Academy of Pediatrics will continue to hold its own childhood vaccine schedule, as it has since the 1930s.

Contemporary Pediatrics sat down with Tina Q. Tan, MD, FAAP, FIDSA, FPIDS, to discuss what's known about the variant. She also discusses the latest on the vaccine for children aged younger than 5 years.

Currently, Vimkunya is FDA-approved for use among individuals aged 12 years and older.

The BLA for clesrovimab was based on results demonstrated in the phase 2b/3 CLEVER trial among healthy pre-term and full-term infants.